Answers are grounded in this paper and cite their sources.
Fabry disease is an under-recognized X-linked lysosomal storage disorder characterized by the accumulation of trihexosylceramides in multifarious tissues, leading to end-organ damage, including progressive renal failure. Antecedent screening studies worldwide have shown inconsistent prevalence in the hemodialysis population. We conducted this study to screen for Fabry disease in patients undergoing dialysis at a tertiary care hospital.
No takes yet. Share an insight, caveat, or question.
Batta et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: